首页> 外文期刊>Clinical and experimental hypertension: CEH >Cardiac mechanical dysfunction induced by ischemia-reperfusion in perfused heart isolated from stroke-prone spontaneously hypertensive rats.
【24h】

Cardiac mechanical dysfunction induced by ischemia-reperfusion in perfused heart isolated from stroke-prone spontaneously hypertensive rats.

机译:从易中风自发性高血压大鼠中分离出的灌注心脏中,缺血再灌注引起的心脏机械功能障碍。

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the difference in mechanical function after ischemia and reperfusion between Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) or stroke-prone SHR (SHRSP) using the isolated working heart model, in order to examine postischemic mechanical dysfunction in the severely hypertrophied heart. Systolic blood pressure of SHRSP was higher than that of SHR and WKY, and the left ventricular wall in SHRSP was thicker than in WKY. Mechanical dysfunction of the heart during reperfusion following ischemia (11 min) in SHRSP was severer than that in SHR and WKY, and recovery of the cardiac energy charge potential (ECP) level in SHRSP was lower than that in SHR and WKY. Twenty-five, 12 and 11 min-ischemia in WKY, SHR and SHRSP, respectively, caused a similar level of cardiac mechanical damage. Also, the ECP levels were almost equivalent among them at the end of 20 min reperfusion following each time of ischemia. Under each ischemic condition, a Ca2+-channel blocker, diltiazem, and an adenosine potentiator, dilazep, produced a beneficial effect on the post-ischemic dysfunction in SHR and WKY. However, neither cardioprotective drug led to recovery of the mechanical dysfunction of the heart during reperfusion following ischemia in SHRSP. Thus, the severely hypertrophied heart such as that in SHRSP was more susceptible to cardiac reperfusion dysfunction, than the moderately hypertrophied heart such as that in SHR. These results suggest that the cardioprotective effects of drugs may be deteriorated in severe hypertrophied hearts.
机译:我们使用隔离的工作心脏模型调查了Wistar-Kyoto大鼠(WKY)和自发性高血压大鼠(SHR)或中风倾向性SHR(SHRSP)在缺血和再灌注后机械功能的差异,以检查缺血性再灌注中的机械功能障碍严重肥大的心脏。 SHRSP的收缩压高于SHR和WKY,SHRSP的左心室壁比WKY厚。 SHRSP缺血后(11分钟)再灌注期间心脏的机械功能障碍比SHR和WKY严重,并且SHRSP的心脏能量充电电位(ECP)恢复低于SHR和WKY。 WKY,SHR和SHRSP分别发生25分钟,12分钟和11分钟的局部缺血,造成相似程度的心脏机械损伤。同样,每次缺血后20分钟再灌注结束时,ECP水平几乎相等。在每种缺血状态下,Ca2 +通道阻滞剂地尔硫卓和腺苷增强剂地拉西普对SHR和WKY的缺血后功能障碍均产生有益作用。但是,在SHRSP缺血后的再灌注过程中,没有一种心脏保护药物可导致心脏机械功能障碍的恢复。因此,诸如SHRSP中的严重肥大的心脏比诸如SHR中的中度肥大的心脏更容易受到心脏再灌注功能障碍的影响。这些结果表明,在严重肥大的心脏中,药物的心脏保护作用可能会恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号